Artificial Intelligence B2C China Currency E-Commerce Expansion Fraud Healthcare Insurance Internet Renminbi Retail Technology Yuan
China has tightened regulations surrounding online prescription drug sales with the recent release of new compliance guidelines by the National Medical Products Administration. The guidelines, set to regulate the expanding market for patients seeking branded and innovative medicines, are a response to the need for enhanced oversight. First introduced for public review in September 2025, the final version of the guidelines emphasizes the importance of keeping daily review volumes within a “reasonable range”. The online sales of prescription drugs in China underwent a significant shift about two decades ago when online sales were banned. Subsequent to relaxations in policies through…
News Timeline:
Track the development of this news story across the Internet.